APAC Medtech Commercial Growth Case Studies
Marketing leadership that shows up in pipeline, not just activity.
Fifteen years leading go-to-market across APAC medtech in previous regional leadership roles. The pattern was the same each time: fragmented multi-market activity turned into a measurable commercial engine. Here is how that work translates into what Catalyst Advisory APAC brings to growth-stage medtech.
Previous regional leadership role | 11 markets across ASEAN, Korea and ANZ
Implemented governance to funnel discipline: generated $145M+ opportunity pipeline
Marketing performance, pipeline visibility & commercial intelligence
THE CHALLENGE
100+ brands across mature and emerging healthcare systems, and no consistent view of what marketing contributed to revenue.
THE APPROACH
• Built a CRM and business intelligence analytics layer with defined KPIs and a reporting cadence across portfolio and campaigns
• Ran campaigns driven by customer insight and competitive strategy
• Directed a competitive and market intelligence programme that fed planning and resource allocation
THE RESULT
✓ $145M+ opportunity pipeline generated
✓ Sales conversion lifted from 7% to 33%
✓ Regional leadership gained a single, consistent view of marketing performance
What it means for you: If your team can’t yet show what marketing contributes to pipeline, this is the first thing I’d build.
Previous regional leadership role | 13 APAC markets including Greater China, Japan and India
Data-driven GTM strategy transformation of APAC business: +29% revenue in Year 1 across 13 markets
Multi-market launch, integration and channel execution
THE CHALLENGE
One portfolio, 13 markets at very different levels of clinical, regulatory and commercial maturity.
THE APPROACH
• Adapted regional strategy to each market and prioritised investment toward emerging segments
• Wrote multi-country launch playbooks covering field readiness, surgeon training and customer engagement
• Restructured distributor channels and led commercial training to keep delivery consistent across markets
• Led the APAC integration of the an acquired business acquisition across 12 countries, recognised internally as a model for multi-market adoption
THE RESULT
✓ +29% revenue growth in Year 1
✓ A repeatable playbook for launching and integrating across markets
What it means for you: Expanding into new APAC markets does not mean rebuilding from scratch each time. It means the right framework and the right sequencing.
Previous regional leadership role | 15 APAC markets
Expert APAC commercial planning and excellence in product launch execution: 41 launches in 3 years
Launch systems, portfolio rationalisation & scalable execution
THE CHALLENGE
Launch execution varied by market, effort was duplicated, and low-performing products were absorbing resources.
THE APPROACH
• Built a launch-readiness toolkit covering strategy documents, surgeon education, sales tools and engagement plans, shared across markets to cut duplication
• Used performance analysis to rationalise 103 product lines (20,000 SKUs) and redirect spend to where it grows
• Prioritised significant investment in HCP training infrastructure against adoption and return
THE RESULT
✓ 41 product launches delivered on one toolkit
✓ Direct P&L improvement from portfolio rationalisation
✓ Awarded Global Best Regional Leader for cross-functional execution and commercial delivery
What it means for you: A growing company needs systems that scale before headcount does.
KOL advocacy clinicians trust
Previous regional leadership roles
THE CHALLENGE
In regulated, evidence-led markets, clinical credibility drives adoption, and it has to be built within HCP engagement and FMV guidelines.
THE APPROACH
• Identified high-potential HCPs and developed them into credible clinical advocates
• Used imaging centres as peer reference sites for clinical team education
• Built KOL faculty pipelines across SEA and APAC to drive surgical technique adoption
• Designed medical education programmes including anatomy labs, cadaveric workshops, case observation and clinical evidence presentations tailored to local needs
THE RESULT
Increased customer NPS and stronger technique adoption across markets, delivered inside compliance guardrails.
TAKEAWAY
What it means for you: Your KOL strategy should be an adoption engine, not a speaker roster.
Want to see where your marketing engine stands?
Diagnose first, build systems that outlast the engagement, and tie marketing to revenue. Catalyst Advisory APAC brings that discipline to clients without a full-time CMO.
Book your free 1-hour Strategic Audit
New Client Form
